EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Parental perspectives following the implementation of advanced hybrid closed‐loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia

Sin-Ting Tiffany Lai iD, Sara E Styles, Alisa Boucsein, Yongwen Zhou iD, Venus Michaels, Craig Jefferies iD, Esko Wilshire, Martin I De Bock, Benjamin J Wheeler iD

Diabetic Medicine · 2025

DOI: 10.1111/dme.15448 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Sin-Ting Tiffany Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Parents, Insulin Infusion Systems, Insulin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The CO-PILOT trial was funded by Lions New Zealand District 202F, Lloyd Morgan Lions Clubs Charitable Trust, Otago Southland Diabetes Research Trust, Lottery G….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To identify from a parental perspective facilitators and barriers of effective implementation of advanced hybrid closed‐loop (AHCL) therapy in children and adolescents with type 1 diabetes (T1D) with elevated glycaemia.

Methods

Semi‐structured interviews were conducted with parents of participants while in a post‐trial extension phase of the CO‐PILOT randomized controlled trial. The Capability, Opportunity, Motivation, Behaviour Model and Theoretical Domain Framework informed the interviews and framework analysis.

Results

Eleven parents of 9 children and adolescents were interviewed. The median age of their children and adolescents was 14.2 years (IQR 13.3–14.7) with median HbA1c 78 mmol/mol (IQR 75–86) (9.3% IQR 9–10) before starting AHCL. Facilitators of implementing AHCL therapy included the following: (1) knowledge acquired from training, (2) establishing routines and action plans, (3) remote glucose monitoring, (4) achievement of glycaemic goals through automation, (5) children/adolescents' capability to use AHCL independently, (6) improved outcomes incentivized continued AHCL, (7) optimism about sustained improvements and (8) social support from healthcare providers, school staff, peers and parents. Barriers to AHCL implementation included the following: (1) challenges with device usability, (2) need for technical support, (3) forgotten knowledge and skills, (4) non‐adherence to best practices, (5) negative social influences, (6) physical and psychosocial burden and (7) negative emotions.

Conclusions

This study provides comprehensive insights into parental perspectives of influences on implementing AHCL therapy in children and adolescents with elevated glycaemia. As parents remain key partners in diabetes care, these findings inform successful implementation of AHCL and development of future diabetes technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1ParentsInsulin Infusion SystemsInsulinHypoglycemic AgentsHumansAdolescentChildMaleFemaleBlood Glucose Self-MonitoringBlood GlucoseGlycemic ControlGlycated HemoglobinPancreas, Artificial

Stichwörter der Autor:innen

advanced hybrid closed loopartificial pancreasautomated insulin deliverychildren and adolescentparentstype 1 diabetes

Substanzen

InsulinBlood GlucoseHypoglycemic AgentsGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
  • Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
  • The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China.
  • Paediatric Endocrinology, Starship Children's Health, Te Whatu Ora, Health NZ, Auckland, New Zealand.
  • Liggins Institute and Department of Paediatrics, University of Auckland, Auckland, New Zealand.
  • Department of Paediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand.

ORCID-Profile: Sin-Ting Tiffany Lai, Yongwen Zhou, Craig Jefferies, Benjamin J Wheeler

Förderung

  • The CO-PILOT trial was funded by Lions New Zealand District 202F, Lloyd Morgan Lions Clubs Charitable Trust, Otago Southland Diabetes Research Trust, Lottery G…

Zitieren

APA

Lai, S. T., Styles, S. E., Boucsein, A., Zhou, Y., Michaels, V., Jefferies, C., Wilshire, E., De Bock, M. I., & Wheeler, B. J. (2025). Parental perspectives following the implementation of advanced hybrid closed‐loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia. Diabetic Medicine. https://doi.org/10.1111/dme.15448

Vancouver

Lai ST, Styles SE, Boucsein A, Zhou Y, Michaels V, Jefferies C, et al. Parental perspectives following the implementation of advanced hybrid closed‐loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia. Diabetic Medicine. 2025. doi:10.1111/dme.15448

BibTeX
@article{Lai2025,
  author = {Lai, Sin-Ting Tiffany and Styles, Sara E and Boucsein, Alisa and Zhou, Yongwen and Michaels, Venus and Jefferies, Craig and Wilshire, Esko and De Bock, Martin I and Wheeler, Benjamin J},
  title = {Parental perspectives following the implementation of advanced hybrid closed‐loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia},
  journal = {Diabetic Medicine},
  year = {2025},
  doi = {10.1111/dme.15448}
}
Kostenlos starten →